PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG
The International Journal of Neuropsychopharmacology May 27, 2016 Filip Tylš, Michaela Viktorinová, Dominika Prokopcova et al. 10 citations
Objective: Schizophrenia patients have a higher prevalence of type 2 diabetes mellitus than the general population, and even first-episode, drug-naive (FEDN) patients with schizophrenia have shown a higher prevalence of impaired glucose tolerance (IGT) than the general population.We aimed to investigate the prevalence of abnormal glucose tolerance after glucose loading, and to examine the...
DOI: 10.1093/ijnp/pyw041.506 (opens in new tab)
Full text (opens in new tab)
Psilocybin
Electroencephalography
Clinical trial
Audiology
+1